Paper975113
Angiogenesis induction by tumors, embryonic tissues, and lymphocytes.
Auerbach R and 2 others. Cancer Res, 1976. Cited by 139 papers, by iCite.
Cite this record
ConductScience Library. Angiogenesis induction by tumors, embryonic tissues, and lymphocytes. Papers, record 975113. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/975113
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Embryo, Mammalian | Major topic |
| Lymphocytes | Major topic |
| Neoplasms, Experimental | Major topic |
| Angiogenesis Inducing Agents | |
| Animals | |
| Chick Embryo | |
| Deer | |
| Mice | |
| Rabbits |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42753094 | The chick embryo chorioallantoic membrane as an in vivo assay to study the skin in melanoma and other skin pathological conditions. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42753094 | PubMed |
| 39290081 | From ex ovo to in vitro: xenotransplantation and vascularization of mouse embryonic kidneys in a microfluidic chip. | Lab Chip | 2024 | https://conductscience.org/library/papers/39290081 | PubMed |
| 35008876 | Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008876 | PubMed |
| 34449673 | Experimental Models to Study Skin Wound Healing with a Focus on Angiogenesis. | Med Sci (Basel) | 2021 | https://conductscience.org/library/papers/34449673 | PubMed |
| 32776283 | The CAM Assay as an Alternative In Vivo Model for Drug Testing. | Handb Exp Pharmacol | 2021 | https://conductscience.org/library/papers/32776283 | PubMed |
| 32754814 | Avians as a Model System of Vascular Development. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/32754814 | PubMed |
| 27313463 | Clinical features and treatment of squamous cell carcinoma of the breast. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27313463 | PubMed |
| 25468608 | Avians as a model system of vascular development. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25468608 | PubMed |
| 25138280 | The chicken chorioallantoic membrane model in biology, medicine and bioengineering. | Angiogenesis | 2014 | https://conductscience.org/library/papers/25138280 | PubMed |
| 24971349 | CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24971349 | PubMed |
| 23864768 | The effect of anti-inflammatory and antimicrobial herbal remedy PADMA 28 on immunological angiogenesis and granulocytes activity in mice. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/23864768 | PubMed |
| 19701697 | The tumor microenvironment: the making of a paradigm. | Cancer Microenviron | 2009 | https://conductscience.org/library/papers/19701697 | PubMed |
| 19528456 | Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474). | Anticancer Res | 2009 | https://conductscience.org/library/papers/19528456 | PubMed |
| 17491698 | Shell-less chick embryo culture as an alternative in vitro model to investigate glucose-induced malformations in mammalian embryos. | Rev Diabet Stud | 2005 | https://conductscience.org/library/papers/17491698 | PubMed |
| 15201853 | The first evidence of the tumor-induced angiogenesis in vivo by using the chorioallantoic membrane assay dated 1913. | Leukemia | 2004 | https://conductscience.org/library/papers/15201853 | PubMed |
| 7721119 | Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy. | Graefes Arch Clin Exp Ophthalmol | 1995 | https://conductscience.org/library/papers/7721119 | PubMed |
| 7680044 | The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/7680044 | PubMed |
| 7507210 | Endothelial-cell-specific regulation of von Willebrand factor gene expression. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/7507210 | PubMed |
| 7426304 | Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7426304 | PubMed |
| 7205675 | Feto-maternal histoincompatibility and placental blood flow. | J Physiol | 1980 | https://conductscience.org/library/papers/7205675 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/975113
GET https://conductscience.org/api/papers/v1/975113/cited_by?page=2